Cannabis use among cancer patients and survivors in the United States: a systematic review.

ABSTRACT:

Background

How cannabis products are being used by cancer patients and survivors in the United States is poorly understood. This study reviewed observational data to understand the modes, patterns, reasons, discontinuation, and adverse experiences of cannabis use.

Methods

PubMed and PsycINFO database searches were conducted between May 2022 and November 2022. Of the 1162 studies identified, 27 studies met the inclusion criteria. The intercoder agreement was strong (0.81).

Results

The majority (74%) of the studies were cross-sectional in design. Study samples were approximately equal proportions of men and women and majority White participants. The prevalence of cannabis use based on national samples ranged between 4.8% and 22%. The most common modes of cannabis intake

SUBMITTER: Amin S 

PROVIDER: S-EPMC10868394 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature